Aβ deposition inhibitor screen using synthetic amyloid

Nature Biotechnology

Volumn 15, Issue 3, 1997, Pages 258-263

  Esler, William P ^a   Stimson, Evelyn R ^a   Ghilardi, Joseph R ^b   Felix, Arthur M ^d   Lu, Yi An ^c   Vinters, Harry V ^e   Mantyh, Patrick W ^b   Maggio, John E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WILLIAM PATERSON UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer s disease; A deposition; Congo red; High thoughput screen; Structure activity

Indexed keywords

AMYLOID BETA PROTEIN; CONGO RED;

ALZHEIMER DISEASE; AMINO ACID METABOLISM; ANIMAL TISSUE; ARTICLE; DEMENTIA; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0030996676     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0397-258     Document Type: Article

References (37)

1. Hardy, J. and Allsop, D. 1991. Amyloid deposition as the central event in the etiology of Alzheimer’s disease. Trends Pharmacol. Sci. 12:383-388.
2. Selkoe, D.J. 1994. Alzheimer’s disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53:438-447.
3. Vinters, H.V., Wang, Z.Z., and Secor, D.L. 1996. Brain parenchymal and microvascular amyloid in Alzheimer’s disease. Brain. Pathol. 6:179-195.
4. Schenk, D.B., Russell, R.E., May, P., Little, S., Panetta, J., Lieberburg, I., et al. 1995. Therapeutic approaches related to amyloid-β peptide and Alzheimer’s disease. J. Medic. Chem. 38:4141-4154.
5. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C, et al. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523-527
6. LaFerla, F.M., Tinkle, B.T., Bieberich, C.J., Haudenschild, C.C., and Jay, G. 1995. The Alzheimer’s Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genetics 9:21-29.
7. Cummings, B.J. and Cotman, C.W. 1995. Image analysis of β-amyloid load in Alzheimer’s disease and relation to dementia severity. Lancet 326:1524-15287.
8. Schellenberg, G.D. 1995. Genetic dissection of Alzheimer’s disease, a heterogeneous disorder. Proc. Natl. Acad. Sci. USA 92:8552-8559.
9. Selkoe, D.J. 1996. Amyloid β-protein and the genetics of Alzheimer’s disease. J. Biol. Chem. 271:18295-18298.
10. Scheuner, D., Eckman, C, Jensen, M., Song, X., Citron, M., Suzuki, N. et al. 1996. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nature Medicine 2:864-870.
11. Seubert, P., Vigo-Pelfrey, O, Esch, F., Lee, M., Dovey, H., Davis, D., et al. 1992. Isolation and quantification of soluble Alzheimer’s β-peptide from biological fluids. Nature 359:325-327.
12. Haass, C, Schlossmacher, M.G., Hung, A.Y, Vigo-Pelfre, C., Mellon, A., Ostaszewski, B.L., et al. 1992. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325.
13. Kirschner, D.A., Inouye, H., Duffy, L.K., Sinclair, A., Lind, M., and Selkoe, D.J. 1987. Synthetic peptide homologous to β protein from Alzheimer’s disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 84:6953-6957.
14. Jarrett, J.T. and Lansbury, P.T. Jr. 1993. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73:1055-1058.
15. Zheng, H., Jiang, M., Trumbauer, M.E., Siriinathsinghji, D.J., Hopkins, R., Smith, D.W., et al. 1995. Beta-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomoter activity. Cell 81:525-553.
16. Tomiyama, T., Shoji, A., Kataoka, K-I., Suwa, Y., Asano, S., Kaneko, H., and Endo, N. 1996. Inhibition of amyloid β-protein aggregation and neurotoxicity by rifampicin. J. Biol. Chem. 271:6839-6844.
17. Wood, S.J., MacKenzie, L, Maleeff, B., Hurle, M.R., and Wetzel, R. 1996. Selective inhibition of Aβ fibril formation. J. Biol. Chem. 271:4086-4092.
18. Pollack, S.J., Sadlere, I.I.J., Hawtin, S.R., Tailor, V.J., and Shearman, M.S. 1995. Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure specific fashion. Neurosci. Lett. 197:211-214.
19. Soto, C, Kindy, M.S., Baumann, M., and Frangione, B. 1996. Inhibition of Alzheimer’s amyloidosis by peptides that prevent β-sheet conformation. Biochem. Biophys. Res. Com. 226:672-680.
20. Tjernberg, L.O., Naslund, J., Lindqvist, F., Johansson, J., Karlstrom, A.R., Thyberg, J., et al 1996. Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J. Biochem. 271:8545-8548.
21. Maggio, J.E., and Mantyh, P.W. 1996. Brain amyloid—a physiochemical perspective. Brain. Pathol. 6:147-162.
22. Lomakin, A., Chung, D.S., Benedek, G.B., Kirschner, D.A., and Teplow, D.B. 1996. On the nucleation and growth of amyloid β-protein fibrils. Proc. Nat. Acad. Sci. USA 93:1125-1129.
23. Esler, W.P., Stimson, E.R., Ghilardi, J.R., Vinters, H.V., Lee, J.P., Mantyh, P.W., et al. 1996. In vitro growth of Alzheimer’s disease β-amyloid plaques displays first-order kinetics. Biochemistry 35:749-757.
24. Naiki, H. and Nakakuki, K. 1996. First-order kinetic model of Alzheimer’s β-amyloid fibril extension in vitro. Lab. Invest. 74:374-383.
25. Mantyh, P.W., Stimson, E.R., Ghilardi, J.R., Allen, C.J., Dahl, CE., Whitcomb, D.C., et al. 1991. Reversible in vitro growth of Alzheimer disease β-amyloid plaques. Bull. Clin. Neurosci. 56:73-85.
26. Maggio, J.E., Stimson, E.R., Ghilardi, J.R., Allen, C.J., Dahl, CE., Whitcomb, D.C, et al. 1992. Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc. Natl. Acad. Sci. USA 89:5462-5466.
27. 1H NMR of Aβ amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry 34:5191-5200.
28. Esler, W.R, Stimson, E.R., Ghilardi, J.R., Lu, Y.-A., Felix, A.M., Vinters, H.V., et al. 1996. Point substitution in the central hydrophobic cluster of a human β-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry 44:13914-13921.
29. Weldon, D.T., Cleary, D.P., Esler, W.P., Ghilardi, J.R., O’Hare, E., Rogers, S.D., et al. 1996. Neurotoxicity of Aβ peptide: confocal imaging of cellular changes induced by β-amyloid in rat CNS in vivo. Soc. Neurosci. Abs. 22:475.
30. Evans, K.C., Berger, E.P., Cho, C.-G., Weisgraber, K.H., and Lansbury, P.T. Jr. 1995. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92:763-767.
31. Kelly, J.W. 1996. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6:11-17.
32. Hyman, B.T., West, H.L, Rebek, G.W., Buldyrev, S.V., Mantegna, R.N., Ukleja, M., et al. 1995. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc. Nat. Acad. Sci. USA 92:3586-3590.
33. 1-40 labels amyloid deposits in the aged primate brain in vivo. NeuroReport 7:2607-2511.
34. Fraser, P.E., Nguyen, J.T., Inouye, H., Surewicz, W.K., Selkoe, D.J., Podlisny, M.B., et al. 1992. Fibril formation by rodent, Dutch-Hemorrhagic analogs of Alzheimer ß-protein. Biochemistry 31:10716-10723
35. Esler, W.P., Stimson, E.R., Jennings, J.J., Ghilardi, J.R., Mantyh, P.W., and Maggio, J.E. 1996. Zinc-induced aggregation of human and rat β-amyloid peptides in vitro. J. Neurochem. 66:723-732.
36. Mantyh, P.W., Ghilardi, J.R., Rogers, S., DeMaster, E., Allen, C.J., Stimson, E.R., et al. 1993. Aluminum, iron and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61: 1171-1174.
37. Podlisny, M.B., Ostazewski, B.L., Sqazzo, S.L., Koo, E.H., Rydell, R.E., Teplow, D.B., et al. 1995. Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270: 9564-9570.